232 related articles for article (PubMed ID: 16375669)
1. Fungal infections of the skin: infection process and antimycotic therapy.
Borgers M; Degreef H; Cauwenbergh G
Curr Drug Targets; 2005 Dec; 6(8):849-62. PubMed ID: 16375669
[TBL] [Abstract][Full Text] [Related]
2. Current therapy of dermatophytosis.
Degreef HJ; DeDoncker PR
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S25-30. PubMed ID: 8077504
[TBL] [Abstract][Full Text] [Related]
3. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
[TBL] [Abstract][Full Text] [Related]
4. [New antifungal agents in the treatment of superficial dermatomycoses].
Degreef H
Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
[TBL] [Abstract][Full Text] [Related]
5. Dermatophytosis: the management of fungal infections.
Gupta AK; Ryder JE; Chow M; Cooper EA
Skinmed; 2005; 4(5):305-10. PubMed ID: 16282753
[TBL] [Abstract][Full Text] [Related]
6. Azole Resistance in Dermatophytes: Prevalence and Mechanism of Action.
Ghannoum M
J Am Podiatr Med Assoc; 2016; 106(1):79-86. PubMed ID: 26895366
[TBL] [Abstract][Full Text] [Related]
7. Treatments for common superficial fungal infections.
Aly R; Forney R; Bayles C
Dermatol Nurs; 2001 Apr; 13(2):91-4, 98-9; quiz 100-1. PubMed ID: 11917313
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
9. An overview of topical antifungal therapy in dermatomycoses. A North American perspective.
Gupta AK; Einarson TR; Summerbell RC; Shear NH
Drugs; 1998 May; 55(5):645-74. PubMed ID: 9585862
[TBL] [Abstract][Full Text] [Related]
10. Identification and antifungal susceptibility of fungi isolated from dermatomycoses.
Silva LB; de Oliveira DB; da Silva BV; de Souza RA; da Silva PR; Ferreira-Paim K; Andrade-Silva LE; Silva-Vergara ML; Andrade AA
J Eur Acad Dermatol Venereol; 2014 May; 28(5):633-40. PubMed ID: 23556501
[TBL] [Abstract][Full Text] [Related]
11. The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes.
Korting HC; Schöllmann C
J Dtsch Dermatol Ges; 2009 Jan; 7(1):11-9, 11-20. PubMed ID: 18479501
[TBL] [Abstract][Full Text] [Related]
12. Naftifine: A Topical Allylamine for Superficial Dermatophytosis.
Trailokya AA; Shirsat AB; Madhu R; Shah B
J Assoc Physicians India; 2023 May; 71(5):11-12. PubMed ID: 37355825
[TBL] [Abstract][Full Text] [Related]
13. Current concepts in systemic and topical therapy for superficial mycoses.
Millikan LE
Clin Dermatol; 2010 Mar; 28(2):212-6. PubMed ID: 20347665
[TBL] [Abstract][Full Text] [Related]
14. Antifungal agents: an overview. Part II.
Gupta AK; Sauder DN; Shear NH
J Am Acad Dermatol; 1994 Jun; 30(6):911-33; quiz 934-6. PubMed ID: 7619094
[TBL] [Abstract][Full Text] [Related]
15. Combination of amorolfine with various antifungal drugs in dermatophytosis.
Polak A
Mycoses; 1993; 36(1-2):43-9. PubMed ID: 8316261
[TBL] [Abstract][Full Text] [Related]
16. Biochemical basis for the activity and selectivity of oral antifungal drugs.
Vanden Bossche H; Marichal P; Gorrens J; Coene MC
Br J Clin Pract Suppl; 1990 Sep; 71():41-6. PubMed ID: 2091733
[TBL] [Abstract][Full Text] [Related]
17. Mycology - an update Part 3: Dermatomycoses: topical and systemic therapy.
Nenoff P; Krüger C; Paasch U; Ginter-Hanselmayer G
J Dtsch Dermatol Ges; 2015 May; 13(5):387-410; quiz 411. PubMed ID: 25918080
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of the novel azole antifungal agent r126638.
Odds F; Ausma J; Van Gerven F; Woestenborghs F; Meerpoel L; Heeres J; Vanden Bossche H; Borgers M
Antimicrob Agents Chemother; 2004 Feb; 48(2):388-91. PubMed ID: 14742185
[TBL] [Abstract][Full Text] [Related]
19. Topical and systemic antifungals in dermatology practice.
Durdu M; Ilkit M; Tamadon Y; Tolooe A; Rafati H; Seyedmousavi S
Expert Rev Clin Pharmacol; 2017 Feb; 10(2):225-237. PubMed ID: 27868472
[TBL] [Abstract][Full Text] [Related]
20. Overview of topical therapy for common superficial fungal infections and the role of new topical agents.
Brennan B; Leyden JJ
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S3-8. PubMed ID: 9039198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
